User login
Talking with your patients about COPD
Nearly half of all primary care physicians say that the biggest barrier to the diagnosis of chronic obstructive pulmonary disease (COPD) is getting patients to fully report their symptoms, according to the National Heart, Lung, and Blood Institute. To get patients talking and to help them overcome their fears and misconceptions, the NHLBI provides “barrier breakers”—tips to help improve the provider-patient dialogue. This resource is available at: http://www.nhlbi.nih.gov/health/educational/copd/event-listing/awareness-month/pdfs/2013-Talking-with-your-Patients-about-COPD.pdf
Nearly half of all primary care physicians say that the biggest barrier to the diagnosis of chronic obstructive pulmonary disease (COPD) is getting patients to fully report their symptoms, according to the National Heart, Lung, and Blood Institute. To get patients talking and to help them overcome their fears and misconceptions, the NHLBI provides “barrier breakers”—tips to help improve the provider-patient dialogue. This resource is available at: http://www.nhlbi.nih.gov/health/educational/copd/event-listing/awareness-month/pdfs/2013-Talking-with-your-Patients-about-COPD.pdf
Nearly half of all primary care physicians say that the biggest barrier to the diagnosis of chronic obstructive pulmonary disease (COPD) is getting patients to fully report their symptoms, according to the National Heart, Lung, and Blood Institute. To get patients talking and to help them overcome their fears and misconceptions, the NHLBI provides “barrier breakers”—tips to help improve the provider-patient dialogue. This resource is available at: http://www.nhlbi.nih.gov/health/educational/copd/event-listing/awareness-month/pdfs/2013-Talking-with-your-Patients-about-COPD.pdf
Your patient has questions about anticoagulants? This resource provides answers
What should I know about anticoagulants (or antiplatelet agents)?
Could anticoagulants cause problems?
The answers to these patient questions, as well as a list of related resources, are provided in a patient fact sheet available through the American Heart Association: http://www.heart.org/idc/groups/heart-public/@wcm/@hcm/documents/downloadable/ucm_300338.pdf.
What should I know about anticoagulants (or antiplatelet agents)?
Could anticoagulants cause problems?
The answers to these patient questions, as well as a list of related resources, are provided in a patient fact sheet available through the American Heart Association: http://www.heart.org/idc/groups/heart-public/@wcm/@hcm/documents/downloadable/ucm_300338.pdf.
What should I know about anticoagulants (or antiplatelet agents)?
Could anticoagulants cause problems?
The answers to these patient questions, as well as a list of related resources, are provided in a patient fact sheet available through the American Heart Association: http://www.heart.org/idc/groups/heart-public/@wcm/@hcm/documents/downloadable/ucm_300338.pdf.
Tips for Coping With Insomnia
Could a complementary approach help your patient with insomnia?
Relaxation techniques, acupuncture, and dietary supplements are among the complementary health approaches that patients may consider when struggling with insomnia. But how effective—and safe—are they? A fact sheet from the National Center for Complementary and Alternative Medicine provides useful guidance and is available at: https://nccih.nih.gov/sites/nccam.nih.gov/files/Get_The_Facts_Sleep_Disorders_04-24-2014.pdf
Relaxation techniques, acupuncture, and dietary supplements are among the complementary health approaches that patients may consider when struggling with insomnia. But how effective—and safe—are they? A fact sheet from the National Center for Complementary and Alternative Medicine provides useful guidance and is available at: https://nccih.nih.gov/sites/nccam.nih.gov/files/Get_The_Facts_Sleep_Disorders_04-24-2014.pdf
Relaxation techniques, acupuncture, and dietary supplements are among the complementary health approaches that patients may consider when struggling with insomnia. But how effective—and safe—are they? A fact sheet from the National Center for Complementary and Alternative Medicine provides useful guidance and is available at: https://nccih.nih.gov/sites/nccam.nih.gov/files/Get_The_Facts_Sleep_Disorders_04-24-2014.pdf
A resource to help patients choose a safe weight-loss program
Patients interested in losing weight through a weight-loss program are likely to have many questions when it comes to choosing a safe and effective option. This guide from the Weight-control Information Network, available at http://www.niddk.nih.gov/health-information/health-topics/weight-control/choosing-safe-successful-weight-loss-program/Documents/Choosingprogram0208.pdf, addresses such issues as where to start, what to look for in a weight-loss program, and what to avoid.
Patients interested in losing weight through a weight-loss program are likely to have many questions when it comes to choosing a safe and effective option. This guide from the Weight-control Information Network, available at http://www.niddk.nih.gov/health-information/health-topics/weight-control/choosing-safe-successful-weight-loss-program/Documents/Choosingprogram0208.pdf, addresses such issues as where to start, what to look for in a weight-loss program, and what to avoid.
Patients interested in losing weight through a weight-loss program are likely to have many questions when it comes to choosing a safe and effective option. This guide from the Weight-control Information Network, available at http://www.niddk.nih.gov/health-information/health-topics/weight-control/choosing-safe-successful-weight-loss-program/Documents/Choosingprogram0208.pdf, addresses such issues as where to start, what to look for in a weight-loss program, and what to avoid.
Encouraging baby boomers to get tested for hepatitis C
More than 75% of adults infected with hepatitis C are baby boomers. To educate these patients on why they should get tested and how to make sense of test results, the Centers for Disease Control and Prevention has put together a fact sheet. It’s available at http://www.cdc.gov/knowmorehepatitis/media/pdfs/factsheet-boomers.pdf.
More than 75% of adults infected with hepatitis C are baby boomers. To educate these patients on why they should get tested and how to make sense of test results, the Centers for Disease Control and Prevention has put together a fact sheet. It’s available at http://www.cdc.gov/knowmorehepatitis/media/pdfs/factsheet-boomers.pdf.
More than 75% of adults infected with hepatitis C are baby boomers. To educate these patients on why they should get tested and how to make sense of test results, the Centers for Disease Control and Prevention has put together a fact sheet. It’s available at http://www.cdc.gov/knowmorehepatitis/media/pdfs/factsheet-boomers.pdf.
A new class of drugs for systolic heart failure: The PARADIGM-HF study
A large Phase 3 trial found that a combination drug that contains the angiotensin II receptor blocker valsartan and the neprilysin inhibitor sacubitril was superior to the angiotensin-converting enzyme inhibitor enalapril in terms of death and hospitalization for heart failure in patients with heart failure with reduced ejection fraction. The Cleveland Clinic Journal of Medicine provides an overview of the study at http://www.ccjm.org/topics/cardiology/single-article-page/a-new-class-of-drugs-for-systolic-heart-failure-the-paradigm-hf-study/3c10470f58f8d999ac5a167730cc1515.html, along with the implications this new drug may have on the care of patients with chronic heart failure in the future.
A large Phase 3 trial found that a combination drug that contains the angiotensin II receptor blocker valsartan and the neprilysin inhibitor sacubitril was superior to the angiotensin-converting enzyme inhibitor enalapril in terms of death and hospitalization for heart failure in patients with heart failure with reduced ejection fraction. The Cleveland Clinic Journal of Medicine provides an overview of the study at http://www.ccjm.org/topics/cardiology/single-article-page/a-new-class-of-drugs-for-systolic-heart-failure-the-paradigm-hf-study/3c10470f58f8d999ac5a167730cc1515.html, along with the implications this new drug may have on the care of patients with chronic heart failure in the future.
A large Phase 3 trial found that a combination drug that contains the angiotensin II receptor blocker valsartan and the neprilysin inhibitor sacubitril was superior to the angiotensin-converting enzyme inhibitor enalapril in terms of death and hospitalization for heart failure in patients with heart failure with reduced ejection fraction. The Cleveland Clinic Journal of Medicine provides an overview of the study at http://www.ccjm.org/topics/cardiology/single-article-page/a-new-class-of-drugs-for-systolic-heart-failure-the-paradigm-hf-study/3c10470f58f8d999ac5a167730cc1515.html, along with the implications this new drug may have on the care of patients with chronic heart failure in the future.
Prediabetes and metabolic syndrome: Current trend
Evidence-based recommendations for the management of prediabetes and metabolic syndrome focus on lifestyle changes. To learn the most effective strategies for the prevention of type 2 diabetes and management of metabolic syndrome, see Clinician Reviews: http://www.clinicianreviews.com/cecme/cecme-activities/article/prediabetes-and-metabolic-syndrome-current-trend/813d59c90c52e07bafca5f70211f1f50.html?tx_ttnews%5BsViewPointer%5D=1
Evidence-based recommendations for the management of prediabetes and metabolic syndrome focus on lifestyle changes. To learn the most effective strategies for the prevention of type 2 diabetes and management of metabolic syndrome, see Clinician Reviews: http://www.clinicianreviews.com/cecme/cecme-activities/article/prediabetes-and-metabolic-syndrome-current-trend/813d59c90c52e07bafca5f70211f1f50.html?tx_ttnews%5BsViewPointer%5D=1
Evidence-based recommendations for the management of prediabetes and metabolic syndrome focus on lifestyle changes. To learn the most effective strategies for the prevention of type 2 diabetes and management of metabolic syndrome, see Clinician Reviews: http://www.clinicianreviews.com/cecme/cecme-activities/article/prediabetes-and-metabolic-syndrome-current-trend/813d59c90c52e07bafca5f70211f1f50.html?tx_ttnews%5BsViewPointer%5D=1
What to do when your depressed patient develops mania
Manic symptoms that may arise in the course of your patient’s treatment for depression can signal the presence of bipolar disorder, another underlying medical problem, or the adverse effects of a prescribed antidepressant. To find out how best to identify and manage manic symptoms that can arise during the course of a patient’s treatment for depression, go to Current Psychiatry: http://www.currentpsychiatry.com/specialty-focus/depressive-disorders/article/what-to-do-when-your-depressed-patient-develops-mania/f3218a38f6603114ff2f9d9bfc21acfb.html
Manic symptoms that may arise in the course of your patient’s treatment for depression can signal the presence of bipolar disorder, another underlying medical problem, or the adverse effects of a prescribed antidepressant. To find out how best to identify and manage manic symptoms that can arise during the course of a patient’s treatment for depression, go to Current Psychiatry: http://www.currentpsychiatry.com/specialty-focus/depressive-disorders/article/what-to-do-when-your-depressed-patient-develops-mania/f3218a38f6603114ff2f9d9bfc21acfb.html
Manic symptoms that may arise in the course of your patient’s treatment for depression can signal the presence of bipolar disorder, another underlying medical problem, or the adverse effects of a prescribed antidepressant. To find out how best to identify and manage manic symptoms that can arise during the course of a patient’s treatment for depression, go to Current Psychiatry: http://www.currentpsychiatry.com/specialty-focus/depressive-disorders/article/what-to-do-when-your-depressed-patient-develops-mania/f3218a38f6603114ff2f9d9bfc21acfb.html
Dabigatran vs warfarin before cardioversion of atrial arrhythmias
A quality improvement project supported the use of the anticoagulants dabigatran or warfarin before a planned cardioversion, but several factors need to be considered before one is prescribed. To read the full article, go to Federal Practitioner: http://www.fedprac.com/specialty-focus/anticoagulation/article/evaluation-of-dabigatran-vs-warfarin-before-cardioversion-of-atrial-arrhythmias/52c81005de9c5a202ab7f4acc2e38232.html
A quality improvement project supported the use of the anticoagulants dabigatran or warfarin before a planned cardioversion, but several factors need to be considered before one is prescribed. To read the full article, go to Federal Practitioner: http://www.fedprac.com/specialty-focus/anticoagulation/article/evaluation-of-dabigatran-vs-warfarin-before-cardioversion-of-atrial-arrhythmias/52c81005de9c5a202ab7f4acc2e38232.html
A quality improvement project supported the use of the anticoagulants dabigatran or warfarin before a planned cardioversion, but several factors need to be considered before one is prescribed. To read the full article, go to Federal Practitioner: http://www.fedprac.com/specialty-focus/anticoagulation/article/evaluation-of-dabigatran-vs-warfarin-before-cardioversion-of-atrial-arrhythmias/52c81005de9c5a202ab7f4acc2e38232.html